Search

Your search keyword '"Sallevelt, Bastiaan T G M"' showing total 23 results
Start Over Author "Sallevelt, Bastiaan T G M"
23 results on '"Sallevelt, Bastiaan T G M"'

1. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

Author

Sallevelt, Bastiaan T. G. M., Egberts, Toine C. G., Huibers, Corlina J. A., Ietswaart, Jimmy, Drenth-van Maanen, A. Clara, Jennings, Emma, O’Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François-Xavier, Spinewine, Anne, van Puijenbroek, Eugène P., Wilting, Ingeborg, and Knol, Wilma

Published
2022
Full Text
View/download PDF

3. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

Sallevelt, Bastiaan T. G. M., Huibers, Corlina J. A., Heij, Jody M. J. Op, Egberts, Toine C. G., van Puijenbroek, Eugène P., Shen, Zhengru, Spruit, Marco R., Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O’Mahony, Denis, Wilting, Ingeborg, and Knol, Wilma

Published
2022
Full Text
View/download PDF

4. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system

Author

Crowley, Erin K., Sallevelt, Bastiaan T. G. M., Huibers, Corlina J. A., Murphy, Kevin D., Spruit, Marco, Shen, Zhengru, Boland, Benoît, Spinewine, Anne, Dalleur, Olivia, Moutzouri, Elisavet, Löwe, Axel, Feller, Martin, Schwab, Nathalie, Adam, Luise, Wilting, Ingeborg, Knol, Wilma, Rodondi, Nicolas, Byrne, Stephen, and O’Mahony, Denis

Published
2020
Full Text
View/download PDF

5. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, Knol, Wilma, Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, and Knol, Wilma

Abstract

BACKGROUND: The Screening Tool of Older Persons' Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into software algorithms and implemented in a clinical decision support system (CDSS) to facilitate their use in clinical practice.OBJECTIVE: Our objective was to determine the frequency of CDSS-generated STOPP/START signals and their subsequent acceptance by a pharmacotherapy team in a hospital setting.DESIGN AND METHODS: Hospitalised older patients with polypharmacy and multimorbidity allocated to the intervention arm of the OPERAM (OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly) trial underwent a CDSS-assisted structured medication review in four European hospitals. We evaluated the frequency of CDSS-generated STOPP/START signals and the subsequent acceptance of these signals by a trained pharmacotherapy team consisting of a physician and pharmacist after evaluation of clinical applicability to the individual patient, prior to discussing pharmacotherapy optimisation recommendations with the patient and attending physicians. Multivariate linear regression analysis was used to investigate potential patient-related (e.g. age, number of co-morbidities and medications) and setting-related (e.g. ward type, country of inclusion) determinants for acceptance of STOPP and START signals.RESULTS: In 819/826 (99%) of the patients, at least one STOPP/START signal was generated using a set of 110 algorithms based on STOPP/START v2 criteria. Overall, 39% of the 5080 signals were accepted by the pharmacotherapy team. There was a high variability in the frequency and the subsequent acceptance of the individual STOPP/START criteria. The acceptance ranged from 2.5 to 75.8% for the top ten most frequently generated STOPP and START signals. The signal to stop a drug without a clini

Published
2022

6. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

Afd Pharmacoepi & Clinical Pharmacology, Sub Natural Language Processing, Pharmacoepidemiology and Clinical Pharmacology, Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Sub Natural Language Processing, Pharmacoepidemiology and Clinical Pharmacology, Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, and Knol, Wilma

Published
2022

7. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (SLuc) Département de pharmacie, UCL - (MGD) Département de pharmacie, Sallevelt, Bastiaan T. G. M., Huibers, Corlina J. A., Heij, Jody M. J. Op, Egberts, Toine C. G., van Puijenbroek, Eugène P., Shen, Zhengru, Spruit, Marco R., Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O’Mahony, Denis, Wilting, Ingeborg, Knol, Wilma, UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (SLuc) Département de pharmacie, UCL - (MGD) Département de pharmacie, Sallevelt, Bastiaan T. G. M., Huibers, Corlina J. A., Heij, Jody M. J. Op, Egberts, Toine C. G., van Puijenbroek, Eugène P., Shen, Zhengru, Spruit, Marco R., Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O’Mahony, Denis, Wilting, Ingeborg, and Knol, Wilma

Abstract

Background The Screening Tool of Older Persons’ Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into software algorithms and implemented in a clinical decision support system (CDSS) to facilitate their use in clinical practice. Objective Our objective was to determine the frequency of CDSS-generated STOPP/START signals and their subsequent acceptance by a pharmacotherapy team in a hospital setting. Design and Methods Hospitalised older patients with polypharmacy and multimorbidity allocated to the intervention arm of the OPERAM (OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly) trial underwent a CDSS-assisted structured medication review in four European hospitals. We evaluated the frequency of CDSS-generated STOPP/START signals and the subsequent acceptance of these signals by a trained pharmacotherapy team consisting of a physician and pharmacist after evaluation of clinical applicability to the individual patient, prior to discussing pharmacotherapy optimisation recommendations with the patient and attending physicians. Multivariate linear regression analysis was used to investigate potential patient-related (e.g. age, number of co-morbidities and medications) and setting-related (e.g. ward type, country of inclusion) determinants for acceptance of STOPP and START signals.

Published
2022

8. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

Author

UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (MGD) Département de pharmacie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de médecine gériatrique, Sallevelt, Bastiaan T. G. M., Egberts, Toine C. G., Huibers, Corlina J. A., Ietswaart, Jimmy, Drenth-van Maanen, A. Clara, Jennings, Emma, O’Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François-Xavier, Spinewine, Anne, van Puijenbroek, Eugène P., Wilting, Ingeborg, Knol, Wilma, UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (MGD) Département de pharmacie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de médecine gériatrique, Sallevelt, Bastiaan T. G. M., Egberts, Toine C. G., Huibers, Corlina J. A., Ietswaart, Jimmy, Drenth-van Maanen, A. Clara, Jennings, Emma, O’Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François-Xavier, Spinewine, Anne, van Puijenbroek, Eugène P., Wilting, Ingeborg, and Knol, Wilma

Abstract

Introduction Multimorbidity and polypharmacy are risk factors for drug-related hospital admissions (DRAs) in the ageing population. DRAs caused by medication errors (MEs) are considered potentially preventable. The STOPP/START criteria were developed to detect potential MEs in older people. Objective The aim of this study was to assess the detectability of MEs with a STOPP/START-based in-hospital medication review in older people with polypharmacy and multimorbidity prior to a potentially preventable DRA. Methods Hospitalised older patients (n = 963) with polypharmacy and multimorbidity from the intervention arm of the OPERAM trial received a STOPP/START-based in-hospital medication review by a pharmacotherapy team. Readmissions within 1 year after the in-hospital medication review were adjudicated for drug-relatedness. A retrospective assessment was performed to determine whether MEs identified at the first DRA were detectable during the in-hospital medication review. Results In total, 84 of 963 OPERAM intervention patients (8.7%) were readmitted with a potentially preventable DRA, of which 72 patients (n = 77 MEs) were eligible for analysis. About half (48%, n = 37/77) of the MEs were not present during the in-hospital medication review and therefore were not detectable at that time. The pharmacotherapy team recommended a change in medication regimen in 50% (n = 20/40) of present MEs, which corresponds to 26% (n = 20/77) of the total identified MEs at readmission. However, these recommendations were not implemented. Conclusion MEs identified at readmission were not addressed by a prior single in-hospital medication review because either these MEs occurred after the medication review (~50%), or no recommendation was given during the medication review (~25%), or the recommendation was not implemented (~25%). Future research should focus on optimisation of the timing and frequency of medication review and the implementation of proposed medication recommendations.

Published
2022

9. Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

Author

Apotheek Klinische Farmacie, Apotheek Onderzoek, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Geriatrie, Geneeskunde, Circulatory Health, Sallevelt, Bastiaan T G M, Egberts, Toine C G, Huibers, Corlina J A, Ietswaart, Jimmy, Drenth-van Maanen, A Clara, Jennings, Emma, O'Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François-Xavier, Spinewine, Anne, van Puijenbroek, Eugène P, Wilting, Ingeborg, Knol, Wilma, Apotheek Klinische Farmacie, Apotheek Onderzoek, Infection & Immunity, Regenerative Medicine and Stem Cells, MS Geriatrie, Geneeskunde, Circulatory Health, Sallevelt, Bastiaan T G M, Egberts, Toine C G, Huibers, Corlina J A, Ietswaart, Jimmy, Drenth-van Maanen, A Clara, Jennings, Emma, O'Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François-Xavier, Spinewine, Anne, van Puijenbroek, Eugène P, Wilting, Ingeborg, and Knol, Wilma

Published
2022

10. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

Sallevelt, Bastiaan T. G. M., primary, Huibers, Corlina J. A., additional, Heij, Jody M. J. Op, additional, Egberts, Toine C. G., additional, van Puijenbroek, Eugène P., additional, Shen, Zhengru, additional, Spruit, Marco R., additional, Jungo, Katharina Tabea, additional, Rodondi, Nicolas, additional, Dalleur, Olivia, additional, Spinewine, Anne, additional, Jennings, Emma, additional, O’Mahony, Denis, additional, Wilting, Ingeborg, additional, and Knol, Wilma, additional

Published
2021
Full Text
View/download PDF

13. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Author

Blum, Manuel R, primary, Sallevelt, Bastiaan T G M, additional, Spinewine, Anne, additional, O’Mahony, Denis, additional, Moutzouri, Elisavet, additional, Feller, Martin, additional, Baumgartner, Christine, additional, Roumet, Marie, additional, Jungo, Katharina Tabea, additional, Schwab, Nathalie, additional, Bretagne, Lisa, additional, Beglinger, Shanthi, additional, Aubert, Carole E, additional, Wilting, Ingeborg, additional, Thevelin, Stefanie, additional, Murphy, Kevin, additional, Huibers, Corlina J A, additional, Drenth-van Maanen, A Clara, additional, Boland, Benoit, additional, Crowley, Erin, additional, Eichenberger, Anne, additional, Meulendijk, Michiel, additional, Jennings, Emma, additional, Adam, Luise, additional, Roos, Marvin J, additional, Gleeson, Laura, additional, Shen, Zhengru, additional, Marien, Sophie, additional, Meinders, Arend-Jan, additional, Baretella, Oliver, additional, Netzer, Seraina, additional, de Montmollin, Maria, additional, Fournier, Anne, additional, Mouzon, Ariane, additional, O’Mahony, Cian, additional, Aujesky, Drahomir, additional, Mavridis, Dimitris, additional, Byrne, Stephen, additional, Jansen, Paul A F, additional, Schwenkglenks, Matthias, additional, Spruit, Marco, additional, Dalleur, Olivia, additional, Knol, Wilma, additional, Trelle, Sven, additional, and Rodondi, Nicolas, additional

Published
2021
Full Text
View/download PDF

14. The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation

Author

Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, de Vries Schultink, Aurelia H M, Sallevelt, Bastiaan T G M, Meinders, Arend Jan, van de Garde, Ewoudt M W, Roescher, Nienke, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, de Vries Schultink, Aurelia H M, Sallevelt, Bastiaan T G M, Meinders, Arend Jan, van de Garde, Ewoudt M W, and Roescher, Nienke

Published
2021

15. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial

Author

UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (MGD) Département de pharmacie, UCL - (SLuc) Département de pharmacie, UCL - SSS/IRSS - Institut de recherche santé et société, Blum, Manuel R, Sallevelt, Bastiaan T G M, Spinewine, Anne, O’Mahony, Denis, Moutzouri, Elisavet, Feller, Martin, Baumgartner, Christine, Roumet, Marie, Jungo, Katharina Tabea, Schwab, Nathalie, Bretagne, Lisa, Beglinger, Shanthi, Aubert, Carole E, Wilting, Ingeborg, Thevelin, Stefanie, Murphy, Kevin, Huibers, Corlina J A, Drenth-van Maanen, A Clara, Boland, Benoit, Crowley, Erin, Eichenberger, Anne, Meulendijk, Michiel, Jennings, Emma, Adam, Luise, Roos, Marvin J, Gleeson, Laura, Shen, Zhengru, Marien, Sophie, Meinders, Arend-Jan, Baretella, Oliver, Netzer, Seraina, de Montmollin, Maria, Fournier, Anne, Mouzon, Ariane, O’Mahony, Cian, Aujesky, Drahomir, Mavridis, Dimitris, Byrne, Stephen, Jansen, Paul A F, Schwenkglenks, Matthias, Spruit, Marco, Dalleur, Olivia, Knol, Wilma, Trelle, Sven, Rodondi, Nicolas, UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (MGD) Département de pharmacie, UCL - (SLuc) Département de pharmacie, UCL - SSS/IRSS - Institut de recherche santé et société, Blum, Manuel R, Sallevelt, Bastiaan T G M, Spinewine, Anne, O’Mahony, Denis, Moutzouri, Elisavet, Feller, Martin, Baumgartner, Christine, Roumet, Marie, Jungo, Katharina Tabea, Schwab, Nathalie, Bretagne, Lisa, Beglinger, Shanthi, Aubert, Carole E, Wilting, Ingeborg, Thevelin, Stefanie, Murphy, Kevin, Huibers, Corlina J A, Drenth-van Maanen, A Clara, Boland, Benoit, Crowley, Erin, Eichenberger, Anne, Meulendijk, Michiel, Jennings, Emma, Adam, Luise, Roos, Marvin J, Gleeson, Laura, Shen, Zhengru, Marien, Sophie, Meinders, Arend-Jan, Baretella, Oliver, Netzer, Seraina, de Montmollin, Maria, Fournier, Anne, Mouzon, Ariane, O’Mahony, Cian, Aujesky, Drahomir, Mavridis, Dimitris, Byrne, Stephen, Jansen, Paul A F, Schwenkglenks, Matthias, Spruit, Marco, Dalleur, Olivia, Knol, Wilma, Trelle, Sven, and Rodondi, Nicolas

Abstract

Objective: To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital. Design: Cluster randomised controlled trial. Setting: 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors. Participants: 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term). Intervention: Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person’s prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing. Main outcome measure: Primary outcome was first drug related hospital admission within 12 months. Results: 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug relate

Published
2021

19. Conversion of STOPP/START version 2 into coded algorithms for software implementation: A multidisciplinary consensus procedure

Author

MS Geriatrie, Apotheek Opleiding, Huibers, Corlina J A, Sallevelt, Bastiaan T G M, de Groot, Dominique A, Boer, Maarten J, van Campen, Jos P C M, Davids, Cathelijn J, Hugtenburg, Jacqueline G, Vermeulen Windsant-Van den Tweel, Annemieke M A, van Hout, Hein P J, van Marum, Rob J, Meulendijk, Michiel C, MS Geriatrie, Apotheek Opleiding, Huibers, Corlina J A, Sallevelt, Bastiaan T G M, de Groot, Dominique A, Boer, Maarten J, van Campen, Jos P C M, Davids, Cathelijn J, Hugtenburg, Jacqueline G, Vermeulen Windsant-Van den Tweel, Annemieke M A, van Hout, Hein P J, van Marum, Rob J, and Meulendijk, Michiel C

Published
2019

20. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system

Author

Crowley, Erin K, Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Murphy, Kevin D, Spruit, Marco, Shen, Zhengru, Boland, Benoît, Spinewine, Anne, Dalleur, Olivia, Moutzouri, Elisavet, Löwe, Axel, Feller, Martin, Schwab, Nathalie, Adam, Luise, Wilting, Ingeborg, Knol, Wilma, Rodondi, Nicolas, Byrne, Stephen, and O'Mahony, Denis

Subjects
610 Medicine & health, 360 Social problems & social services, 3. Good health
Abstract

BACKGROUND Several approaches to medication optimisation by identifying drug-related problems in older people have been described. Although some interventions have shown reductions in drug-related problems (DRPs), evidence supporting the effectiveness of medication reviews on clinical and economic outcomes is lacking. Application of the STOPP/START (version 2) explicit screening tool for inappropriate prescribing has decreased inappropriate prescribing and significantly reduced adverse drug reactions (ADRs) and associated healthcare costs in older patients with multi-morbidity and polypharmacy. Therefore, application of STOPP/START criteria during a medication review is likely to be beneficial. Incorporation of explicit screening tools into clinical decision support systems (CDSS) has gained traction as a means to improve both quality and efficiency in the rather time-consuming medication review process. Although CDSS can generate more potential inappropriate medication recommendations, some of these have been shown to be less clinically relevant, resulting in alert fatigue. Moreover, explicit tools such as STOPP/START do not cover all relevant DRPs on an individual patient level. The OPERAM study aims to assess the impact of a structured drug review on the quality of pharmacotherapy in older people with multi-morbidity and polypharmacy. The aim of this paper is to describe the structured, multi-component intervention of the OPERAM trial and compare it with the approach in the comparator arm. METHOD This paper describes a multi-component intervention, integrating interventions that have demonstrated effectiveness in defining DRPs. The intervention involves a structured history-taking of medication (SHiM), a medication review according to the systemic tool to reduce inappropriate prescribing (STRIP) method, assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2), followed by shared decision-making with both patient and attending physician. The developed method integrates patient input, patient data, involvement from other healthcare professionals and CDSS-assistance into one structured intervention. DISCUSSION The clinical and economical effectiveness of this experimental intervention will be evaluated in a cohort of hospitalised, older patients with multi-morbidity and polypharmacy in the multicentre, randomized controlled OPERAM trial (OPtimising thERapy to prevent Avoidable hospital admissions in the Multi-morbid elderly), which will be completed in the last quarter of 2019. TRIAL REGISTRATION Universal Trial Number: U1111-1181-9400 Clinicaltrials.gov: NCT02986425, Registered 08 December 2016. FOPH (Swiss national portal): SNCTP000002183. Netherlands Trial Register: NTR6012 (07-10-2016).

21. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity

Author

Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eug��ne P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, and Knol, Wilma

Subjects
610 Medicine & health, 360 Social problems & social services, 3. Good health
Abstract

BACKGROUND The Screening Tool of Older Persons' Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into software algorithms and implemented in a clinical decision support system (CDSS) to facilitate their use in clinical practice. OBJECTIVE Our objective was to determine the frequency of CDSS-generated STOPP/START signals and their subsequent acceptance by a pharmacotherapy team in a hospital setting. DESIGN AND METHODS Hospitalised older patients with polypharmacy and multimorbidity allocated to the intervention arm of the OPERAM (OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid��elderly) trial underwent a CDSS-assisted structured medication review in four European hospitals. We evaluated the frequency of CDSS-generated STOPP/START signals and the subsequent acceptance of these signals by a trained pharmacotherapy team consisting of a physician and pharmacist after evaluation of clinical applicability to the individual patient, prior to discussing pharmacotherapy optimisation recommendations with the patient and attending physicians. Multivariate linear regression analysis was used to investigate potential patient-related (e.g. age, number of co-morbidities and medications) and setting-related (e.g. ward type, country of inclusion) determinants for acceptance of STOPP and START signals. RESULTS In 819/826 (99%) of the patients, at least one STOPP/START signal was generated using a set of 110 algorithms based on STOPP/START v2 criteria. Overall, 39% of the 5080 signals were accepted by the pharmacotherapy team. There was a high variability in the frequency and the subsequent acceptance of the individual STOPP/START criteria. The acceptance ranged from 2.5 to 75.8% for the top ten most frequently generated STOPP and START signals. The signal to stop a drug without a clinical indication was most frequently generated (28%), with more than half of the signals accepted (54%). No difference in mean acceptance of STOPP versus START signals was found. In multivariate analysis, most patient-related determinants did not predict acceptance, although the acceptance of START signals increased in patients with one or more hospital admissions (+ 7.9; 95% confidence interval [CI] 1.6-14.1) or one or more falls in the previous year (+ 7.1; 95% CI 0.7-13.4). A higher number of co-morbidities was associated with lower acceptance of STOPP (- 11.8%; 95% CI - 19.2 to - 4.5) and START (- 11.0%; 95% CI - 19.4 to - 2.6) signals for patients with more than nine and between seven and nine co-morbidities, respectively. For setting-related determinants, the acceptance differed significantly between the participating trial sites. Compared with Switzerland, the acceptance was higher in Ireland (STOPP: + 26.8%; 95% CI 16.8-36.7; START: + 31.1%; 95% CI 18.2-44.0) and in the Netherlands (STOPP: + 14.7%; 95% CI 7.8-21.7). Admission to a surgical ward was positively associated with acceptance of STOPP signals (+ 10.3%; 95% CI 3.8-16.8). CONCLUSION The involvement of an expert team in translating population-based CDSS signals to individual patients is essential, as more than half of the signals for potential overuse, underuse, and misuse were not deemed clinically appropriate in a hospital setting. Patient-related potential determinants were poor predictors of acceptance. Future research investigating factors that affect patients' and physicians' agreement with medication changes recommended by expert teams may provide further insight for implementation in clinical practice. REGISTRATION ClinicalTrials.gov Identifier: NCT02986425.

23. Conversion of STOPP/START version 2 into coded algorithms for software implementation: A multidisciplinary consensus procedure.

Author

Huibers CJA, Sallevelt BTGM, de Groot DA, Boer MJ, van Campen JPCM, Davids CJ, Hugtenburg JG, Vermeulen Windsant-Van den Tweel AMA, van Hout HPJ, van Marum RJ, and Meulendijk MC

Subjects
Aged, Databases, Factual, Female, Humans, Male, Practice Patterns, Physicians' standards, Algorithms, Consensus, Inappropriate Prescribing, Software
Abstract

Background: The rapid digitalization of medical practice has attracted growing interest in developing software applications for clinical guidelines and explicit screening tools to detect potentially inappropriate prescribing, such as STOPP/START criteria. The aim of the current study was to develop and provide logically unambiguous algorithms of STOPP/START criteria version 2, encoded with international disease and medication classification codes, to facilitate the development of software applications for multiple purposes., Methods: A four round multidisciplinary consensus and validation procedure was conducted to develop implementable coded algorithms for software applications of STOPP/START criteria version 2, based on ICD, ICPC, LOINC and ATC classification databases., Results: Consensus was reached for all 34 START criteria and 76 out of 80 STOPP criteria. The resulting 110 algorithms, modeled as inference rules in decision tables, are provided as supplementary data., Conclusion: This is the first study providing implementable algorithms for software applications based on STOPP/START version 2, validated in a computer decision support system. These algorithms could serve as a template for applying STOPP/START criteria version 2 to any software application, allowing for adaptations of the included ICD, ICPC and ATC codes and changing the cut-off levels for laboratory measurements to match local guidelines or clinical expertise., (Copyright © 2019 Elsevier B.V. All rights reserved.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results